396: A new trick for old science, and biotech VCs' scrambled playbook
Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA? Adam is out, so Elaine and Allison dive into the latest news, including how China a...
9 Apr 32min
395: Biotech investors' plea to Trump, and a busy M&A week
How has the Food and Drug Administration's recent decisions on rare disease drugs affected investment trends? Why is Eli Lilly getting into sleep medicine? And where did Allison go on her vacation? W...
2 Apr 31min
394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy
On this week’s episode of "The Readout LOUD": Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You've been warned. Eli Lilly’s deal man Jake van ...
26 Mar 25min
393: A conversation with the 'godfather' of biotech
On this week's episode of "The Readout LOUD," we bring you a special conversation with Stelios Papadapolous, also know as the "godfather" of biotech. He sat down for an on-stage chat with our colleagu...
20 Mar 45min
392: Epstein's pal attempts a biotech comeback, and Prasad exits the FDA
How was a known friend of Jeffrey Epstein able to raise $100 million, with the help of a prominent biotech VC? And will Vinay Prasad return to the Food and Drug Administration for a "three-peat"? Dam...
12 Mar 30min
391: Breaching the IBD efficacy ceiling, and sham surgeries
Will drugmakers finally be able to breach the efficacy ceiling in inflammatory bowel disease? And is the Food and Drug Administration being flexible enough with rare disease treatments? Spyre Therap...
5 Mar 30min
390: FDA turmoil, election intrigue, AI, and more
On "The Readout LOUD" this week: Adam Feuerstein, solo. His usual co-hosts Allison DeAngelis and Elaine Chen took some time off, so Adam manned the podcast mic himself. Adam thought, quite understand...
26 Feb 32min
389: Hims' Super Bowl fallout, and the FDA reverses course
Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening behind-the-scenes with Moderna and the Food and Drug Administration? W...
19 Feb 34min
